CHERIE MOREY: Open Payments
NPI 1972908630 · WESTWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 8 payments from 7 companies in 2025. Trend: 2023 $108 · 2024 $262 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $156 |
| Astellas Pharma US Inc | 1 | $127 |
| Madrigal Pharmaceuticals | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| SERVIER PHARMACEUTICALS LLC | 1 | $21 |
| Kite Pharma, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $17 |
Products named: REZUROCK, Cresemba, REZDIFFRA, XIFAXAN, Oncaspar, Yescarta, NIKTIMVO.
Industry payments across KS — which companies pay providers there.
